Bristol-Myers Squibb Company Ce (CELG-RI)

US — Healthcare Sector
Peers: SNY  GSK  VRTX  CVS  PFE  MCK  HCA  GILD  MDT  AMGN 

Automate Your Wheel Strategy on CELG-RI

With Tiblio's Option Bot, you can configure your own wheel strategy including CELG-RI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol CELG-RI
  • Rev/Share 23.4418
  • Book/Share 8.5941
  • PB 5.0925
  • Debt/Equity 2.9211
  • CurrentRatio 1.2068
  • ROIC 0.1328

 

  • MktCap 88806065612.0
  • FreeCF/Share 7.1636
  • PFCF 6.0918
  • PE 17.5851
  • Debt/Assets 0.5379
  • DivYield 0.0568
  • ROE 0.2957

 

  • Rating B+
  • Score 3
  • Recommendation Neutral
  • P/E Score 1
  • DCF Score 5
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About Bristol-Myers Squibb Company Ce (CELG-RI)

  • IPO Date
  • Website http://www.bms.com
  • Industry Drug Manufacturers - General
  • CEO Christopher S. Boerner
  • Employees 34100
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.